An observational, prospective, open-label to assess effectiveness, safety and tolerability of once-yearly treatment with zoledronic acid in osteoporotic patients in a real-world setting (AZURE).
2020-07-04
عنوان الدراسة
An observational, prospective, open-label to assess effectiveness, safety and tolerability of once-yearly treatment with zoledronic acid in osteoporotic patients in a real-world setting (AZURE).
داعم الدراسة
Novartis
دواء الدراسة
Zoledronic acid
رقم بروتوكول الدراسة
CZOL446H-MAX-SA-01
حالة الدراسة
Completed
موقع الدراسة
King Fahad University Hospital (Al-Khobar), King Khalid University Hospital (Riyadh)
مرحلة الدراسة
4
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.